HWEL Stock Overview
Healthwell Acquisition Corp. I does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Healthwell Acquisition Corp. I Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.47 |
| 52 Week High | US$11.88 |
| 52 Week Low | US$9.14 |
| Beta | 0.049 |
| 11 Month Change | 1.06% |
| 3 Month Change | 1.45% |
| 1 Year Change | 6.40% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 8.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| HWEL | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0% | 2.3% | 0.3% |
| 1Y | 6.4% | 56.7% | 31.1% |
Return vs Industry: HWEL underperformed the US Capital Markets industry which returned 8% over the past year.
Return vs Market: HWEL underperformed the US Market which returned 14.1% over the past year.
Price Volatility
| HWEL volatility | |
|---|---|
| HWEL Average Weekly Movement | 6.0% |
| Capital Markets Industry Average Movement | 4.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HWEL has not had significant price volatility in the past 3 months.
Volatility Over Time: HWEL's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Alyssa Rapp | www.healthwellspac.com |
Healthwell Acquisition Corp. I does not have significant operations. The company focuses on effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire technology-enabled companies in the healthcare industry.
Healthwell Acquisition Corp. I Fundamentals Summary
| HWEL fundamental statistics | |
|---|---|
| Market cap | US$107.92m |
| Earnings (TTM) | US$2.50m |
| Revenue (TTM) | n/a |
43.2x
P/E Ratio0.0x
P/S RatioIs HWEL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HWEL income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | -US$2.50m |
| Earnings | US$2.50m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -1.7% |
How did HWEL perform over the long term?
See historical performance and comparison